Company News in the Life Science Industry

»

Reset 

Global Disposable Medical Gloves Market (2019 to 2028) - Featuring Adventa Berhad, Ansell & B Braun Melsungen Among Others

DUBLIN, June 29, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 29 Jun 2020

FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer

SILVER SPRING, Md., June 29, 2020 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Keytruda (pembrolizumab) for intravenous injection for the first-line treatment of patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient... Read more ››

By: PR Newswire Association LLC. - 29 Jun 2020
Related companies:  U.S. Food and Drug Administration

TopDevz delivers a new custom commission software for the world's largest medical device distributor

SACRAMENTO, June 29, 2020 /PRNewswire/ -- TopDevz, one of America's fastest-growing software consulting firm, announced today the delivery of... Read more ››

By: PR Newswire Association LLC. - 29 Jun 2020

RedHawk Announces Third Quarter FY 2020 Results

LAFAYETTE, Louisiana, June 29, 2020 /PRNewswire/ -- RedHawk Holdings Corp. (OTC: SNDD) ("RedHawk" or the "Company") a diversified holding company engaged in sales and distribution of medical... Read more ››

By: PR Newswire Association LLC. - 29 Jun 2020

Luminex Submits Emergency Use Authorization Request to U.S. FDA for COVID-19 Antibody Test

AUSTIN, Texas, June 29, 2020 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that the company has submitted an Emergency Use Authorization request to the U.S. Food and Drug Administration (FDA) for its xMAP(®) SARS-CoV-2 Multi-Antigen IgG assay. The assay was developed to... Read more ››

By: PR Newswire Association LLC. - 29 Jun 2020
Related companies:  Luminex Corporation

Akero Therapeutics to Announce New Data from NASH Phase 2a BALANCED Study of AKR-001

SOUTH SAN FRANCISCO, Calif., June 29, 2020 /PRNewswire/ -- Akero Therapeutics, Inc. (Nasdaq: AKRO) today announced that the company plans to discuss new efficacy and safety data, including biopsy results, from its Phase 2a BALANCED study of AKR-001 in patients with biopsy-confirmed nonalcoholic... Read more ››

By: PR Newswire Association LLC. - 29 Jun 2020
Related companies:  Akero Therapeutics, Inc.

Hillrom To Host Fiscal Third Quarter 2020 Earnings Conference Call And Webcast

CHICAGO, June 29, 2020 /PRNewswire/ -- Hillrom (NYSE: HRC) will host its fiscal third quarter 2020 earnings conference call and webcast on Friday, July 31, 2020, beginning at 7:30 a.m. (CT) / 8:30 a.m. (ET).

Read more ››
By: PR Newswire Association LLC. - 29 Jun 2020

$133.5 Billion Worldwide Medical Supplies Industry to 2025 - Featuring Convatec Group, Abbott & Cook Medical Among Others

DUBLIN, June 29, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 29 Jun 2020

BioMarin Promotes Company Veteran, Brian R. Mueller, to Executive Vice President, CFO

SAN RAFAEL, Calif., June 29, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced the promotions of Brian R. Mueller to Executive Vice President, Chief Financial Officer and of Andrea L. Acosta to Group Vice President, Chief Accounting Officer. Mr. Mueller had been... Read more ››

By: PR Newswire Association LLC. - 29 Jun 2020
Related companies:  BioMarin Pharmaceutical Inc.

OmniSeq Offers Differentiating Platform to Clinically Detect Rare Genetic Alterations to Identify Patients Eligible for New, Targeted Therapy for Lung and Thyroid Cancer

BUFFALO, N.Y., June 29, 2020 /PRNewswire/ -- OmniSeq(®), an innovator in next generation sequencing (NGS) in oncology, today announced the benefits of its OmniSeq Advance(®) comprehensive genomic and immune profiling assay to detect the presence of rare alterations in the RET gene... Read more ››

By: PR Newswire Association LLC. - 29 Jun 2020
Related companies:  OmniSeq, LLC

Outlook into the Protective Clothing for Life Sciences Industry Global Market to 2028 - Growth in Biotechnology and Healthcare Spending Presents Opportunities

DUBLIN, June 29, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 29 Jun 2020

VistaGen Therapeutics Reports Fiscal Year 2020 Results and Provides CNS Pipeline Update

SOUTH SAN FRANCISCO, Calif., June 29, 2020 /PRNewswire/ -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical... Read more ››

By: PR Newswire Association LLC. - 29 Jun 2020
Related companies:  VistaGen Therapeutics, Inc.

Medicure Announces Normal Course Issuer Bid

WINNIPEG, MB, June 29, 2020 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH) (OTC: MCUJF), a pharmaceutical company, is pleased to announce that the TSX Venture Exchange ("TSXV") has accepted the Company's notice of intention to make a normal course... Read more ››

By: PR Newswire Association LLC. - 29 Jun 2020
Related companies:  Medicure Inc.

Aquestive Therapeutics Files IND for Pharmacokinetic Clinical Trials of AQST-108 (Sublingual Film Formulation Delivering Systemic Epinephrine) for Anaphylaxis Treatment

Read more ››
By: GlobenewsWire - 29 Jun 2020
Related companies:  Aquestive Therapeutics, Inc.

Intercept Receives Complete Response Letter from FDA for Obeticholic Acid for the Treatment of Fibrosis Due to NASH

Read more ››
By: GlobenewsWire - 29 Jun 2020
Related companies:  Intercept Pharmaceuticals Inc.

Aprea Therapeutics Appoints Fouad Namouni, M.D. and Richard Peters, M.D., Ph.D. to Board of Directors

Read more ››
By: GlobenewsWire - 29 Jun 2020
Related companies:  Aprea Therapeutics, Inc.

Tonix Pharmaceuticals Announces Enrollment of Phase 3 RELIEF Trial of TNX-102 SL for Management of Fibromyalgia is Ahead of Schedule

Read more ››
By: GlobenewsWire - 29 Jun 2020
Related companies:  Tonix Pharmaceuticals Holding Corp.

GenMark Diagnostics Announces Commercial Launch of its ePlex® Respiratory Pathogen Panel 2 (RP2)

Read more ››
By: GlobenewsWire - 29 Jun 2020
Related companies:  GenMark Diagnostics, Inc.

Altimmune Receives Award from U.S. Department of Defense to Fund Phase 1/2 Clinical Trial of T-COVID™ in Outpatients with Early COVID-19

Read more ››
By: GlobenewsWire - 29 Jun 2020
Related companies:  Altimmune, Inc.

Aptose Announces FDA Allowance of IND for Phase 1a/b Study of CG-806 in Acute Myeloid Leukemia

Read more ››
By: GlobenewsWire - 29 Jun 2020
Related companies:  Aptose Biosciences Inc. | Aptose Biosciences
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23 24  25 »

Explore our database of over 50,000 companies